Cargando…
Beta-blocker use and COPD mortality: a systematic review and meta-analysis
BACKGROUND: Despite the benefits of beta-blockers in patients with established or sub-clinical coronary artery disease, their use in patients with chronic obstructive pulmonary disease (COPD) has been controversial. Currently, no systematic review has examined the impact of beta-blockers on mortalit...
Autores principales: | Etminan, Mahyar, Jafari, Siavash, Carleton, Bruce, FitzGerald, John Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499441/ https://www.ncbi.nlm.nih.gov/pubmed/22947076 http://dx.doi.org/10.1186/1471-2466-12-48 |
Ejemplares similares
-
The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018) -
Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review
por: Bahadori, Katayoon, et al.
Publicado: (2007) -
Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies
por: Du, Qingxia, et al.
Publicado: (2014) -
Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis
por: Alshabanat, A., et al.
Publicado: (2015) -
Beta-blocker under-use in COPD patients
por: Lim, Kuan Pin, et al.
Publicado: (2017)